
The national lockdown has hit pharmaceutical companies hard as restrictions on movement of goods and people imposed by the police led to a disruption in their supply chain, potentially blunting India's fight against Covid-19.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dp9rUJ
via
Latest News of India
Post a Comment